Radiopharm Theranostics announces extraordinary general meeting for shareholder approvals

• Radiopharm Theranostics will hold an extraordinary general meeting in Australia on about Sept. 11, 2026.
• Shareholders will vote on approvals tied to the company’s capital raising, including issuance of shares under an Australian placement.
• The meeting will also seek approval for a share purchase plan and the issue of options linked to the placement and plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Radiopharm Theranostics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-082101), on July 28, 2026, and is solely responsible for the information contained therein.